Definitive Healthcare (Definitive Healthcare) Debt-to-EBITDA : 21.99 (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Definitive Healthcare Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Definitive Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $16.1 Mil. Definitive Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $248.0 Mil. Definitive Healthcare's annualized EBITDA for the quarter that ended in Mar. 2024 was $12.0 Mil. Definitive Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 21.99.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Definitive Healthcare's Debt-to-EBITDA or its related term are showing as below:

DH' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.11 Med: 10.57 Max: 11.73
Current: -1.11

During the past 5 years, the highest Debt-to-EBITDA Ratio of Definitive Healthcare was 11.73. The lowest was -1.11. And the median was 10.57.

DH's Debt-to-EBITDA is ranked worse than
100% of 423 companies
in the Healthcare Providers & Services industry
Industry Median: 2.63 vs DH: -1.11

Definitive Healthcare Debt-to-EBITDA Historical Data

The historical data trend for Definitive Healthcare's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Definitive Healthcare Debt-to-EBITDA Chart

Definitive Healthcare Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

N/A

10.62

11.73

10.52

-1.11

Definitive Healthcare Quarterly Data
	Jul19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-EBITDA	Get a 7-Day Free Trial													-552.24	19.52	-0.27	14.21	21.99

Competitive Comparison of Definitive Healthcare's Debt-to-EBITDA

For the Health Information Services subindustry, Definitive Healthcare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Definitive Healthcare's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Definitive Healthcare's Debt-to-EBITDA falls into.

Definitive Healthcare Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Definitive Healthcare's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(15.989	+	251.939)	/	-241.227
	=	-1.11

Definitive Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(16.057	+	247.957)	/	12.008
	=	21.99

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.

Definitive Healthcare (NAS:DH) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Definitive Healthcare Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Definitive Healthcare's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Definitive Healthcare (Definitive Healthcare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Definitive Healthcare Corp (NAS:DH) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

492 Old Connecticut Path, Suite 401, Framingham, MA, USA, 01701

Website

https://www.definitivehc.com

Definitive Healthcare Corp is a leading provider of healthcare commercial intelligence. The company's solutions provide accurate and comprehensive information on healthcare providers and their activities to help customers optimize everything from product development to go-to-market planning and sales and marketing execution. Geographically, it derives a majority of its revenue from the United States.

Executives

Carrie Lazorchak	officer: Chief Revenue Officer	C/O DEFINITIVE HEALTHCARE CORP., 492 OLD CONNECTICUT PATH, SUITE 401, FRAMINGHAM MA 01701
Scott G Stephenson	director	C/O VERISK ANALYTICS, INC., 545 WASHINGTON BOULEVARD, JERSEY CITY NJ 07310-1686
Sea Vii Management, Llc	director, 10 percent owner	ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent International Gp, Llc	director, 10 percent owner	800 BOYLSTON STREET SUITE 3300, BOSTON MA 02199
Spectrum Vii Investment Managers' Fund, L.p.	director, 10 percent owner	ONE INTERNATIONAL PLACE, 35TH FLOOR, BOSTON MA 02110
Jason Ronald Krantz	director, 10 percent owner, officer: Chief Executive Officer	C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Jonathan Maack	officer: President	C/O DEFINITIVE HEALTHCARE CORP., 550 COCHITUATE RD, FRAMINGHAM MA 01701
Sastry Chilukuri	director	5 BUDDY LANE, MORRISTOWN NJ 07960
David Randall Winn	director	7900 GLADES ROAD, SUITE 540, BOCA RATON FL 33434
Jeffrey Charles Haywood	director, 10 percent owner	C/O DEFINITIVE HEALTHCARE, LLC, 550 COCHITUATE ROAD, FRAMINGHAM MA 01701
Richard Douglas Booth	officer: Chief Financial Officer	200 CLARENDON STREET, T-9, BOSTON MA 02116
Kathleen A Winters	director	101 COLUMBIA ROAD, MORRISTOWN NJ 07960
Spectrum Vii Co-investment Fund, L.p.	director, 10 percent owner	ONE INTERNATIONAL PLACE, SUITE 3520, BOSTON MA 02110
Advent Global Technology-c Limited Partnership	director, 10 percent owner	PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069
Advent Global Technology-d Limited Partnership	director, 10 percent owner	PRUDENTIAL TOWER, 800 BOYLSTON STREET, BOSTON MA 02199-8069